Jupiter Endovascular Inc: Valuation, Funding & Investors
Jupiter Endovascular Inc is a medical technology startup focused on developing innovative endovascular interventions through its proprietary Transforming Fixation (TFX) platform technology. The TFX-enabled procedures aim to provide enhanced stability, control, and anatomical protection for catheter-based therapies, initially targeting pulmonary embolism with plans to expand into other high-need cardiovascular applications. The company's technology allows for flexible navigation through the vasculature and precise stabilization at treatment sites, potentially expanding the capabilities of endovascular medicine.
Leadership & Board
- Current Number of Employees
- 59
- Current LinkedIn Followers
- 5,431
Latest Estimated Valuation
- Total Amount Raised
- $40M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $40M
- Latest Funding Round
- Series B
Company Momentum
PositiveJupiter Endovascular Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Jupiter Endovascular Inc had 59 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Jupiter Endovascular Inc had 5,431 followers as of November 9, 2026. The number of followers increased by 26 (0.48%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 08, 2025 | Series B | $40.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| LB Investment | Series B |
| Sonder Capital | Series B |
| Senvest Management | Series B |
Similar Companies
A snapshot of private companies similar to Jupiter Endovascular Inc, helping you discover and navigate related company profiles.
Related News and Analysis










